HI
TXMD icon

HBK Investments’s TherapeuticsMD TXMD Stock Holding History

HBK Investments’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-240
Closed -$58K – 1041
2019
Q1 		$58K Buy
+240
New +$63.5K ﹤0.01% 1015
2016
Q1 		– Sell
-942
Closed -$488K – 1127
2015
Q4 		$488K Buy
942
+708
+303% +$261K ﹤0.01% 759
2015
Q3 		$69K Buy
+234
New +$83.2K ﹤0.01% 979

Other funds holding TXMD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments's TXMD Position: Q2 2019 in Review

HBK Investments sold out of TherapeuticsMD (TXMD) in Q2 2019, closing a stake of 240 shares — an estimated $58K sold.

HBK Investments first reported a position in TXMD in Q3 2015 and held it in 3 quarters. The position peaked at $488K in Q4 2015. 148 funds tracked by Wall St. Rank hold TXMD as of Q2 2019.

  • HBK Investments reported no remaining TherapeuticsMD position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 240 TherapeuticsMD shares in Q2 2019, an estimated $58K.
  • HBK Investments first reported a position in TherapeuticsMD in Q3 2015 and held it in 3 quarters.
  • HBK Investments's TherapeuticsMD position peaked at $488K in Q4 2015.
  • 148 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.